scholarly article | Q13442814 |
P356 | DOI | 10.1016/B978-0-12-397900-1.00003-7 |
P698 | PubMed publication ID | 23199488 |
P50 | author | Richard Price | Q42591886 |
Nicholas M. Douglas | Q55175709 | ||
Nicholas M Anstey | Q60043835 | ||
Jeanne Rini Poespoprodjo | Q60043853 | ||
P2860 | cites work | Comparative genomics of the neglected human malaria parasite Plasmodium vivax | Q22122202 |
P921 | main subject | Plasmodium vivax | Q311376 |
pathogenesis | Q372016 | ||
maternal health | Q6786626 | ||
P304 | page(s) | 151-201 | |
P577 | publication date | 2012-01-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Advances in Parasitology | Q15764504 |
P1476 | title | Plasmodium vivax: clinical spectrum, risk factors and pathogenesis | |
P478 | volume | 80 |
Q35877857 | A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions |
Q33412049 | A case of vivax malaria complicated by adult respiratory distress syndrome and successful management with extracorporeal membrane oxygenation |
Q45794588 | A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy |
Q37425725 | Analysis of lymphocytes in patients with Plasmodium vivax malaria and its relation to the annexin-A1 and IL-10. |
Q56342079 | Analysis of the lymphocyte cell population during malaria caused by Plasmodium vivax and its correlation with parasitaemia and thrombocytopaenia |
Q33417944 | Angiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio as indicators of potential severity of Plasmodium vivax malaria in patients with thrombocytopenia |
Q55426170 | Anti-band 3 and anti-spectrin antibodies are increased in Plasmodium vivax infection and are associated with anemia. |
Q33828552 | Asia-Pacific malaria is singular, pervasive, diverse and invisible |
Q28550280 | Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia |
Q26786117 | Association between anthropometry-based nutritional status and malaria: a systematic review of observational studies |
Q38614220 | Case Report: Severe and Complicated Cynomolgi Malaria in a Rhesus Macaque Resulted in Similar Histopathological Changes as Those Seen in Human Malaria. |
Q93211728 | Circulating Neutrophil Extracellular Traps and Neutrophil Activation Are Increased in Proportion to Disease Severity in Human Malaria |
Q37098382 | Comparison of parasite sequestration in uncomplicated and severe childhood Plasmodium falciparum malaria |
Q36109722 | Complicated malaria symptoms associated with Plasmodium vivax among patients visiting health facilities in Mendi town, Northwest Ethiopia |
Q38844689 | Could Plasmodium vivax malaria trigger malnutrition? Revisiting the Bradford Hill criteria to assess a causal relationship between two neglected problems |
Q56359213 | Cytotoxic CD8 T cells recognize and kill Plasmodium vivax-infected reticulocytes |
Q36318958 | DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria Patients. |
Q33563151 | Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles |
Q38597276 | Development of vaccines for Plasmodium vivax malaria |
Q53767337 | Diagnosis and Treatment of Plasmodium vivax Malaria |
Q92249482 | Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials |
Q37239183 | Distribution of Antibodies Specific to the 19-kDa and 33-kDa Fragments of Plasmodium vivax Merozoite Surface Protein 1 in Two Pathogenic Strains Infecting Korean Vivax Malaria Patients. |
Q33891805 | Dynamics of Plasmodium vivax sporogony in wild Anopheles stephensi in a malaria-endemic region of Western India |
Q38892525 | Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation |
Q37630317 | Emerging Pathogens - How Safe is Blood? |
Q96137089 | Empiric Treatment for Suspected Malaria in the United States: A Case Report |
Q35829555 | Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility. |
Q36418183 | Falling Plasmodium knowlesi Malaria Death Rate among Adults despite Rising Incidence, Sabah, Malaysia, 2010-2014. |
Q35962523 | Further Evidence of Increasing Diversity of Plasmodium vivax in the Republic of Korea in Recent Years |
Q30249044 | Global Epidemiology of Plasmodium vivax |
Q34259032 | Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis |
Q33721887 | Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal |
Q41722962 | Heterologous expression of Plasmodium vivax apical membrane antigen 1 (PvAMA1) for binding peptide selection. |
Q54208945 | High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia. |
Q34234390 | Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis |
Q28355362 | Implications of Plasmodium vivax Biology for Control, Elimination, and Research |
Q39316977 | Imported Plasmodium vivax malaria ex Pakistan |
Q35564511 | Incidence of Jaundice in Plasmodium vivax Malaria: A Prospective Study in Moodabidri, South India |
Q34142735 | Influence of age on the haemoglobin concentration of malaria-infected patients in a reference centre in the Brazilian Amazon |
Q38260972 | Innate sensing of malaria parasites |
Q37643622 | KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro |
Q28081463 | Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax |
Q36531296 | Limitations of microscopy to differentiate Plasmodium species in a region co-endemic for Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi |
Q28537653 | Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study |
Q56383949 | Malaria |
Q55463707 | Malaria Elimination: Time to Target All Species. |
Q40055950 | Malaria Pathogenesis |
Q35678578 | Malaria and immunity during pregnancy and postpartum: a tale of two species |
Q35712522 | Malaria eradication and elimination: views on how to translate a vision into reality |
Q64962925 | Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study. |
Q37488090 | Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. |
Q34640080 | Malaria-induced splenic infarction |
Q42338471 | Management of Plasmodium vivax risk and illness in travelers |
Q41996386 | Metabolome-wide association study of peripheral parasitemia in Plasmodium vivax malaria |
Q37642896 | Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals from Dschang, West Cameroon |
Q34686612 | Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia |
Q95818239 | Natural Products as Sources of Antimalarial Drugs: Ethnobotanical and Ethnopharmacological Studies |
Q36560001 | New insights into the Plasmodium vivax transcriptome using RNA-Seq |
Q38892647 | Nitric Oxide-Dependent Endothelial Dysfunction and Reduced Arginine Bioavailability in Plasmodium vivax Malaria but No Greater Increase in Intravascular Hemolysis in Severe Disease. |
Q35328856 | Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells |
Q36063764 | Optimization of a Membrane Feeding Assay for Plasmodium vivax Infection in Anopheles albimanus |
Q35682623 | Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria |
Q60947070 | Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria |
Q33419656 | Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria |
Q47799735 | Pathophysiology, clinical presentation, and treatment of coma and acute kidney injury complicating falciparum malaria |
Q42659378 | Pernicious and threatening Plasmodium vivax as reality |
Q33435123 | Plasmodium cynomolgi infections in rhesus macaques display clinical and parasitological features pertinent to modelling vivax malaria pathology and relapse infections |
Q39530831 | Plasmodium falciparum, but not P. vivax, can induce erythrocytic apoptosis |
Q33741840 | Plasmodium vivax Induced Acute Respiratory Distress Syndrome - A Diagnostic and Therapeutic Dilemma in Preeclampsia |
Q35847037 | Plasmodium vivax Transmission in Africa |
Q37633527 | Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice |
Q56358763 | Platelets kill circulating parasites of all major Plasmodium species in human malaria |
Q58115290 | Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework |
Q35649424 | Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection |
Q30248811 | Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria |
Q33731882 | Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency |
Q38672428 | Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis |
Q37045828 | Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland |
Q35921902 | Sensitive Detection of Plasmodium vivax Using a High-Throughput, Colourimetric Loop Mediated Isothermal Amplification (HtLAMP) Platform: A Potential Novel Tool for Malaria Elimination |
Q37433398 | Stuck in a rut? Reconsidering the role of parasite sequestration in severe malaria syndromes |
Q36176399 | Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia |
Q36003145 | Symptoms and Immune Markers in Plasmodium/Dengue Virus Co-infection Compared with Mono-infection with Either in Peru |
Q58089503 | Tafenoquine for travelers' malaria: evidence, rationale and recommendations |
Q40218474 | The Biology of Plasmodium vivax |
Q27009149 | The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon |
Q28551039 | The Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with Malaria |
Q34969275 | The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea |
Q30619692 | The fluid management of adults with severe malaria |
Q34874961 | The importance of pathogen load |
Q35068767 | The prognostic utility of bedside assessment of adults hospitalized with malaria in Myanmar: a retrospective analysis |
Q89786563 | The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study |
Q48022024 | Tissue-specific immunopathology during malaria infection |
Q28607891 | Towards a strategy for malaria in pregnancy in Afghanistan: analysis of clinical realities and women's perceptions of malaria and anaemia |
Q33713142 | Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome |
Q38603812 | Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study |
Q36952579 | Vivax malaria and bacteraemia: a prospective study in Kolkata, India |
Search more.